V companies public / 10343
AdvanCell
| id | 10343 |
|---|---|
| name | AdvanCell |
| category | Biotech / Pharma |
| hq_city | — |
| hq_state | — |
| hq_country | US |
| metro_area | — |
| region | — |
| website | https://www.advancell.com.au |
| founded_year | — |
| is_public | false |
| firm_type | — |
| description | [subscription] AdvanCell, a clinical-stage radiopharmaceutical company developing targeted alpha therapies for cancer, received a $315 mi... |
| person_count | 0 |
| has_funding | true |
| latest_funding_usd | 315000000.0 |
| nexus_score | — |
| nexus_tier | — |
| updated_at | 2026-07-26T17:24:25.316076+00:00 |